NCT07835152: Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults
- State
- Not started
- Phase
- Phase 3
- People
- 1,000 planned
- Started
- 20 Nov 2026
- Primary completion
- 31 Mar 2029
- Arms
- BR005-036C
- Results
- None posted
- 22 Sep 2026: Trial registered